Adenovirus
1
Pipeline Programs
2
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
375%
Vaccine
125%
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Jazz PharmaceuticalsCA - Palo Alto
3 programs1
BrincidofovirPhase 2Small Molecule1 trial
BrincidofovirN/ASmall Molecule1 trial
BrincidofovirN/ASmall Molecule1 trial
Active Trials
NCT02596997No Longer Available
TevaIsrael - Petach Tikva
1 programAdenovirus Vaccine Pregnancy RegistryN/AVaccine1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Jazz PharmaceuticalsBrincidofovir
Jazz PharmaceuticalsBrincidofovir
TevaAdenovirus Vaccine Pregnancy Registry
Clinical Trials (4)
Total enrollment: 100 patients across 4 trials
Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia
Start: Dec 2018Est. completion: May 20190
Phase 2Withdrawn
Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
N/ANo Longer Available
A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304
Start: Feb 2015Est. completion: Sep 2016100 patients
N/ATerminated
Adenovirus Vaccine Pregnancy Registry
Start: Dec 2011Est. completion: Apr 20140
N/AWithdrawn
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
Small Molecule is the dominant modality (75% of programs)
2 companies competing in this space